semaglutide tirzepatide news today recency 3 Cheaper is coming — and experts think it could reshape diabetes access.⁠ ⁠ Click the link in our bio to read the full story on our website.⁠ ⁠ #diabetes #GLP1 #semaglutide #pharma #medicalnews Eli Lilly's Phase 3 data

Standardisation of hCG, hCG subunits, and developmental research context tests [PMID: 6121215] Laboratory literature summary: Standardisation of hCG, hCG subunits, and developmental research context tests

The primary outcome was newly diagnosed cancer, and the median follow-up duration for all participants was 8 years

Paying attention to how your body responds can help you make better choices over time

Despite these differences, tirzepatide resulted in consistent benefits across multiple domains of heart failure severity, including similar benefits in terms of reduction in heart failure hospitalization or cardiovascular death in both women and men compared with placebo, Borlaug added